Abstract:Abstract Background Limited information exists on postoperative hypocortisolism and hypothalamus–pituitary–adrenal axis recovery in patients with adrenal incidentaloma following unilateral adrenalectomy. We evaluated frequency of postoperative hypocortisolism and predictors for recovery in non-aldosterone-producing adrenocortical adenoma patients after unilateral adrenalectomy. Methods A retrospective analysis of 32 adrenal incidentaloma patients originally included in the ITACA trial (NCT04127552) with confirmed non-aldosterone-producing adrenocortical adenoma undergoing unilateral adrenalectomy from September 2019 to April 2023 was conducted. Preoperative assessments included adrenal MRI, anthropometrics, evaluation of comorbidities, adrenal function assessed via ACTH, urinary free cortisol, and 1 mg dexamethasone suppression test. ACTH and serum cortisol or Short Synacthen test were performed within 6 days, 6 weeks, 6 months, and a year after surgery. Results Six days postoperative, 18.8% of patients had normal adrenal function. Among those with postoperative hypocortisolism, 53.8% recovered by 6 weeks. Patients with earlier adrenal recovery (6 weeks) had lower preoperative 1 mg dexamethasone suppression test (median 1 mg dexamethasone suppression test 76.2 [61.8–111.0] nmol/L vs 260.0 [113.0–288.5] nmol/L, p < 0.001). Univariate analysis showed preoperative 1 mg dexamethasone suppression test negatively related with baseline ACTH levels ( r = − 0.376; p = 0.041) and negatively associated with the 6-week baseline ( r = − 0.395, p = 0.034) and 30-min cortisol levels during Short Synacthen test ( r = − 0.534, p = 0.023). Logistic regression analysis demonstrated preoperative 1 mg dexamethasone suppression test as the only biochemical predictor for 6-week adrenal recovery: ROC curve identified a 1 mg dexamethasone suppression test threshold of 131 nmol/L predicting 6-week recovery with 89.5% sensitivity and 72.7% specificity (AUC 0.87; 95% CI 66.9–98.7, p < 0.001). Other preoperative assessments (tumor size, ACTH levels and anthropometrics) were not associated with postoperative hypothalamus–pituitary–adrenal axis function, but the presence of diabetes was associated with a lower probability of recovery (OR = 24.55, p = 0.036). ACTH levels increased postoperatively in all patients but did not predict hypothalamus–pituitary–adrenal axis recovery. Conclusions The preoperative 1 mg dexamethasone suppression test cortisol value and presence of diabetes are the only relevant predictor of hypothalamus–pituitary–adrenal axis recovery in patients with non-aldosterone- producing adrenocortical adenoma undergoing surgery, regardless other clinical and biochemical variables. Notably, pre- and postoperative ACTH levels did not predict hypothalamus–pituitary–adrenal axis recovery. These findings point towards the potential for saving resources by optimizing their allocation during follow-up assessments for patients with non-aldosterone-producing adrenocortical adenoma undergoing unilateral adrenalectomy.

Analysis of adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism

[Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism]

[Clinical Characteristics and Surgery Outcomes of Unilateral Nodular Adrenal Hyperplasia in Primary Aldosteronism: Study of 145 Cases].

Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism

Prognosis and predicators of complete hypertention improvement after adrenalectomy in patients with primary aldosteronism

Adrenal-sparing Surgery in Patients with Aldosterone-Producing Adenomas

Long-term outcome of unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia

Adrenalectomy for primary aldosteronism and its related surgical characteristics

Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study

Role of unilateral‐cannulating adrenal venous sampling for the subtyping of primary aldosteronism for adrenalectomy: Experience from a low‐volume center

Analysis of the Related Factors of the Hypertension Effective Rate after Retroperitoneal Laparoscopic Adrenalectomy

Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling for the subtyping of primary aldosteronism: a prospective study

The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism

[Cytomegalovirus infection as a cause of intestinal perforation].

THU568 The Impact of Surgical versus Medical Therapy on Renin Plasma Activity, Renal Function, and Hypertension Control in Patients with Primary Aldosteronism

Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism

Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy

Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case

Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for chronic kidney disease manifested after adrenalectomy

A comparative study of postadrenalectomy hyperuricemia and renal impairment in patients with unilateral primary aldosteronism: does histopathology subtype matter?

The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism